1. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1: “Goldilocks” actions at dopamine receptors;Stahl;J Clin Psychiatry,2001
2. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors;Burris;J Pharmacol Exp Ther,2002
3. Bristol-Myers Squibb Company, Otsuka America Pharmaceutical Inc. Abilify™ (aripiprazole) Tablets. http://www.fda.gov/MedWatch/SAFETY/2004/abilify_pi.pdf
4. Aripiprazole: pharmacology, efficacy, safety and tolerability;Kinghorn;Expert Rev Neurother,2005
5. Practice guideline for the treatment of patients with schizophrenia;American Psychiatric Association,2004